Understanding the adverse event experience in the S-TRAC adjuvant trial of sunitinib for high-risk renal cell carcinoma von Wood, Sarah Yenser, Ryan, Joanne C, Clair, Andrew G, George, Daniel J

Volltext

Therapy Management Using Modified 2-Weeks-On/1-Week-Off Dosing Schedule in Patients With Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scen... von Allman, Kimberly D, Ryan, Joanne C, Clair, Andrew, Yenser-Wood, Sarah

Volltext

Management of Older Patients With Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scenario von Roethke, Susan K, Ryan, Joanne C, Wood, Sarah Yenser

Volltext

A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy (RT) in men with PSA recurrent prostate cancer (PC) after radical prostat... von Armstrong, Andrew J., Halabi, Susan, Healy, Patrick, Lee, Robert, Koontz, Bridget F., Moul, Judd W., Mundy, Kelly, Creel, Patricia, Yenser Wood, Sarah, Davis, Kristen, Reimer, Brooke, Nguyen, Minh, Spitz, Avery N., Bratt, Ellen, Kim, Sung, Tran, Phuoc T., Stein, Mark N., Carducci, Michael Anthony, George, Daniel J.

Volltext

A Phase Ib Study of Combined VEGFR and mTOR Inhibition With Vatalanib and Everolimus in Patients With Advanced Renal Cell Carcinoma von Bitting, Rhonda L, Healy, Patrick, Creel, Patricia A, Turnbull, James, Morris, Karla, Wood, Sarah Yenser, Hurwitz, Herbert I, Starr, Mark D, Nixon, Andrew B, Armstrong, Andrew J, George, Daniel J

Volltext